[ Price : $8.95]
FDA says that beginning 3/8, Pfizers Paxlovid that is labeled under a 12/2021 emergency use authorization will no longer be author...[ Price : $8.95]
U.S. Senator Tammy Baldwin (D-WI) writes the four biggest drug companies marketing asthma inhalers urging them to stop unfairly bl...[ Price : $8.95]
Merck says its Phase 3 KEYNOTE-564 trial evaluating Keytruda (pembrolizumab) as an adjuvant treatment in patients with renal cell ...[ Price : $8.95]
Philips Respironics and FDA reach an agreement on the terms of a consent decree over the companys struggles to resolve issues surr...[ Price : $8.95]
FDA issues a guidance entitled Human Gene Therapy Products Incorporating Human Genome Editing.[ Price : $8.95]
Azurity Pharmaceuticals recalls one lot of narcolepsy drug Zenzedi CII (dextroamphetamine sulfate tablets, USP) 30 mg after a repo...[ Price : $8.95]
Merck says data from its Phase 3 AMBASSADOR (A031501)/KEYNOTE-123 trial evaluating Keytruda (pembrolizumab) are favorable for the ...[ Price : $8.95]
FDA grants Google a de novo marketing authorization for its new body temperature app on its latest Pixel 8 Pro smart phone.